Physician profile
Jennifer A Eakin
NPI 1538367024
$2,021.65
in general payments reported to CMS, 2019-2025
20 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $208 · 2021: $213 · 2022: $561 · 2023: $189 · 2024: $284 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $341.45 | 2019-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $318.61 | 2019-2024 | Lifevest |
| Pfizer INC. | $220.68 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $204.72 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $170.26 | 2019-2022 | |
| Medtronic, INC. | $156.45 | 2022-2025 | Linq II |
| E.R. Squibb & Sons, L.L.C. | $121.86 | 2021-2024 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.98 | 2021-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $86.06 | 2021-2024 | Verquvo |
| Abbott Laboratories | $64.97 | 2019-2024 | Gallant |
| Astrazeneca Pharmaceuticals LP | $59.62 | 2021-2024 | Brilinta |
| Amarin Pharma, INC. | $29.05 | 2019-2020 | |
| Irhythm Technologies, INC. | $25.05 | 2019 | |
| Biotronik INC. | $23.90 | 2022 | |
| Heartflow, INC. | $21.45 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $19.39 | 2024 | Nexletol |
| Novo Nordisk INC | $15.45 | 2022 | |
| Allergan, INC. | $14.74 | 2020 | |
| G Medical Diagnostic Services, INC. | $12.77 | 2022 | |
| Vanda Pharmaceuticals INC. | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Eakin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.